News Releases
May 31, 2023
Biodesix to Participate in William Blair’s 43rd Annual Growth Stock Conference
May 25, 2023
Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing
May 24, 2023
Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors
May 18, 2023
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference
May 11, 2023
Biodesix Announces First Quarter 2023 Results and Highlights
Apr 27, 2023
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023
Mar 06, 2023
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights
Feb 28, 2023
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference
Feb 21, 2023
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023